Mitochondrial DNA: A genetic pandora's box

Functional Neurology

Volumn 16, Issue 2, 2001, Pages 103-116

  DiMauro, S ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Mitochondrial DNA (mtDNA); Mitochondrial genetics; Respiratory chain

Indexed keywords

ASCORBIC ACID; CARNITINE; MITOCHONDRIAL DNA; UBIDECARENONE; VITAMIN K GROUP;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GENE SEGREGATION; GENE THERAPY; GENETIC CODE; HAPLOTYPE; HUMAN; INHERITANCE; ISOMETRIC EXERCISE; MITOSIS; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; RESPIRATORY CHAIN; SYMPTOMATOLOGY; ANIMAL; ARTICLE; AWARDS AND PRIZES; GENETICS; INBORN ERROR OF METABOLISM; METABOLISM; MUTATION; PRENATAL DIAGNOSIS;

ANIMALS; AWARDS AND PRIZES; DNA, MITOCHONDRIAL; GENE THERAPY; HAPLOTYPES; HUMANS; METABOLISM, INBORN ERRORS; MITOCHONDRIAL DISEASES; MUTATION; PRENATAL DIAGNOSIS;

EID: 0034945663     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (70)

1. Intramitochondrial fibers with DNA characteristics
2. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
3. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy
4. Mitochondrial encephalomyopathies: Gene mutation
5. Deletions of mitochondrial DNA in Kearns-Sayre syndrome
6. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome
7. Sequence and organization of the human mitochondrial genome
8. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy
9. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy
10. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy
11. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome
12. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene
13. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis
14. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
15. Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene
16. A case of mitochondrial myopathy, lactic acidosis and complex I deficiency
17. Intragenic inversion of mtDNA: A new type of pathogenic mutation in a patient with mitochondrial myopathy
18. Exercise intolerance and the mitochondrial respiratory chain
19. Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene
20. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with Parkinsonism/MELAS overlap syndrome
21. A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy
22. Histiocytoid cardiomyopathy of infancy: Deficiency of reducible cytochrome b in heart mitochondria
23. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria
24. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mtDNA
25. Detection and analysis of mitochondrial DNA and RNA in muscle by in situ hybridization and single-fiber PCR
26. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness
27. Ser(UCN) gene
28. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness
29. Maternally inherited cardiomyopathy: An atypical presentation of the 12S rRNA A1555G mutation
30. A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathy
31. Leber's hereditary optic neuropathy: Biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype
32. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy
33. Mitochondrial mutations and hearing loss: Paradigm for mitochondrial genetics
34. Mitochondrial tRNA mutation associated with non-syndromic deafness
35. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation
36. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy
37. Mitochondrial DNA variation in human evolution and disease
38. Human mtDNA haplogroups associated with high or reduced spermatozoa motility
39. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
40. Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians
41. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high
42. Primary mitochondrial diseases
43. Kearns-Sayre syndrome: Oncocytic transformation of choroid plexus epithelium
44. Myoclonic epilepsy with ragged-red fibers (MERRF): An immunohistochemical study of the brain
45. Mitochondria and heart disease
46. Termination of transcription in human mitochondria: Identification and purification of a DNA binding protein factor that promotes termination
47. Mitochondrial DNA mutations and pathogenesis
48. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation
49. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo
50. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree
51. Metabolic, structural and neuropsychological deficits in mitochondrial encephalomyopathies assessed by 1H MRSI, MRI and neuropsychological testing
52. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes
53. A debut for mito-mouse
54. Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice
55. Transmitochondrial mice: Proof of principle and promises
56. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes: Prevalence of the mutation in an adult population
57. The epidemiology of pathogenic mitochondrial DNA mutations
58. The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities
59. Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation
60. Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA
61. Mitochondrial encephalomyopathies: Therapeutic approaches
62. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
63. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene
64. Reversal of a mitochondrial DNA defect in human skeletal muscle
65. A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy
66. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibers in a patient with a tRNA point mutation and mitochondrial encephalomyopathy
67. Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome
68. Gene shifting: A novel therapy for mitochondrial myopathy
69. Mitochondrial DNA. Small, beautiful and essential
70. Mitochondrial encephalomyopathies